A comprehensive study published in The British Medical Journal has revealed that women who have survived early invasive breast cancer face a modestly increased risk—approximately 2% higher than the general population—of developing a second primary cancer. This research analyzed data from over 475,000 women diagnosed between 1993 and 2016.
The findings indicate that while the risk of a second cancer is elevated, it remains relatively low. For instance, about 13.6% of the participants developed a second primary cancer, primarily in the uterus or lungs, compared to the expected rate in the general population.
Additionally, 5.6% developed breast cancer in the opposite breast, a condition known as contralateral breast cancer, with the risk being higher in younger women.
Dr. David Dodwell, the study’s lead author and a consultant clinical oncologist at the University of Oxford, emphasized that while the risk of new cancers is higher for breast cancer survivors than for other women, these additional risks are small compared to the risks of recurrence and breast cancer death in the majority of women diagnosed with early invasive breast cancer.
The study also examined the impact of various adjuvant therapies on the risk of secondary cancers. Radiation therapy was associated with higher rates of contralateral breast and lung cancer, while endocrine (hormone) therapy was linked to an increased risk of uterine cancer but decreased risk of contralateral breast cancer. Chemotherapy was tied to an increased risk of acute leukemia.
However, it’s important to note that breast cancer treatments have advanced significantly since the 1990s. Modern radiation techniques, for example, now deliver radiation sideways to isolate the breast and protect the lungs, potentially reducing the risk of secondary cancers.
Despite some treatment-related risks, experts agree that the benefits of current therapies outweigh the potential harms. Dr. Jason Aboudi Mouabbi, an assistant professor of breast medical oncology at the University of Texas MD Anderson Cancer Center, stated that the relatively low increase in risk should be reassuring for women with a history of breast cancer.
While the study provides valuable insights, researchers acknowledged certain limitations, including incomplete cancer registry data and a lack of information on participants’ family history, genetic predispositions, and lifestyle factors. Additionally, the study’s findings may not be generalizable to men or individuals from nonwhite racial or ethnic backgrounds, as less than 5% of participants were recorded as nonwhite.
In conclusion, while breast cancer survivors have a slightly elevated risk of developing a second primary cancer, the overall risk remains low. Advancements in treatment and monitoring continue to improve outcomes for these individuals.
YOU MAY ALSO LIKE
Breastfeeding Safe After Breast Cancer, May Support Postpartum Mental Health
Evaluating Menopausal Hormone Therapy for Women with Diabetes
Pregnant Women Using Laptops: Health Risks and Expert Advice
